Genpact Limited (NYSE:G) Receives Average Recommendation of “Hold” from Analysts

Shares of Genpact Limited (NYSE:GGet Free Report) have been assigned a consensus recommendation of “Hold” from the nine research firms that are covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $48.44.

A number of analysts recently issued reports on the stock. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Needham & Company LLC raised their price objective on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Mizuho lifted their price objective on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Robert W. Baird increased their target price on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Finally, Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and lifted their price target for the company from $44.00 to $55.00 in a report on Tuesday, January 21st.

View Our Latest Report on Genpact

Insider Activity at Genpact

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $44.60, for a total value of $606,560.00. Following the transaction, the chief executive officer now owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.80% of the company’s stock.

Institutional Trading of Genpact

A number of hedge funds and other institutional investors have recently made changes to their positions in G. Coppell Advisory Solutions LLC boosted its holdings in Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider’s stock worth $25,000 after buying an additional 503 shares in the last quarter. SRH Advisors LLC purchased a new position in shares of Genpact during the 4th quarter valued at $26,000. Atlas Capital Advisors Inc. increased its stake in shares of Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock worth $26,000 after acquiring an additional 216 shares during the last quarter. Manchester Capital Management LLC purchased a new stake in shares of Genpact during the fourth quarter worth $38,000. Finally, GeoWealth Management LLC boosted its position in Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider’s stock valued at $38,000 after purchasing an additional 583 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors.

Genpact Stock Performance

NYSE G opened at $53.22 on Wednesday. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact has a fifty-two week low of $30.23 and a fifty-two week high of $56.76. The business has a fifty day moving average of $48.00 and a 200-day moving average of $43.42. The stock has a market cap of $9.39 billion, a price-to-earnings ratio of 18.74, a price-to-earnings-growth ratio of 1.84 and a beta of 1.20.

Genpact (NYSE:GGet Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, analysts predict that Genpact will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.28%. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is 23.94%.

Genpact Company Profile

(Get Free Report

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Analyst Recommendations for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.